High-density lipoprotein function, dysfunction, and reverse cholesterol transport.
about
Structural Insights into High Density Lipoprotein: Old Models and New FactsApolipoprotein A-I and CancerFrom evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transportPaired measurements of paraoxonase 1 and serum amyloid A as useful disease markersThe gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseasesThe role of signalling in cellular cholesterol homeostasisHuman paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological rolesHDL-apoA-I exchange: rapid detection and association with atherosclerosisElevated high-density lipoprotein cholesterol and age-related macular degeneration: the Alienor studyThe roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture.Therapeutic ultrasound: Increased HDL-Cholesterol following infusions of acoustic microspheres and apolipoprotein A-I plasmidsHIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammationLipid Lowering Therapy to Modify Plaque Microstructures.Regression of coronary atherosclerosis with infusions of the high-density lipoprotein mimetic CER-001 in patients with more extensive plaque burdenCholesterol and lipoprotein metabolism: Early Career Committee contributionImpact of estimated HDL particle size via the ratio of HDL-C and apoprotein A-I on short-term prognosis of diabetic patients with stable coronary artery disease.Formation of fenestrae in murine liver sinusoids depends on plasmalemma vesicle-associated protein and is required for lipoprotein passage.Alginic acid cell entrapment: a novel method for measuring in vivo macrophage cholesterol homeostasis.HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.Polymorphisms of mouse apolipoprotein A-II alter its physical and functional nature.HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of functionAn agomir of miR-144-3p accelerates plaque formation through impairing reverse cholesterol transport and promoting pro-inflammatory cytokine production.Uncleaved ApoM signal peptide is required for formation of large ApoM/sphingosine 1-phosphate (S1P)-enriched HDL particles.Plant-based, no-added-fat or American Heart Association diets: impact on cardiovascular risk in obese children with hypercholesterolemia and their parents.Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitorsMetabolomics reveals impaired maturation of HDL particles in adolescents with hyperinsulinaemic androgen excess.How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis?HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophagesABCA1 contributes to macrophage deposition of extracellular cholesterol.HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity.Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in HumansCholesteryl Ester Transfer Protein (CETP) expression does not affect glucose homeostasis and insulin secretion: studies in human CETP transgenic miceIdentification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein InteractionSafety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study.Bone and high-density lipoprotein: The beginning of a beautiful friendshipFrail HDLs and stiff arteries in type 2 diabetes in juveniles.VNN1 promotes atherosclerosis progression in apoE-/- mice fed a high-fat/high-cholesterol diet.Why targeting HDL should work as a therapeutic tool, but has not.Acute exposure to apolipoprotein A1 inhibits macrophage chemotaxis in vitro and monocyte recruitment in vivoHepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein.
P2860
Q26770434-E2012AFC-6E8B-4EAE-B6AD-2FDBD94EEDD5Q26776188-7B633C0B-9A77-445A-9A96-1E1345C4015FQ26997647-50FF1311-2208-4E08-942B-D7021656FB3CQ27006749-DF469E1F-7B5D-4F5B-8302-06FCB19692BEQ27021692-0F0DDF33-5DBD-4B34-AADA-FEE1C9DB9092Q28294413-679DD20C-B725-4E5C-AB6B-D57A52132B77Q28395898-6D7B1F92-D9F0-45F7-80CD-8507C78D7D15Q28535779-944041D1-4AA6-4DCF-9DEB-6F4E43F70784Q28540642-7A0035AA-7253-4AF1-9FBF-AEF29235324EQ30240734-8C6CFBC3-C886-4F31-A76A-332C461F2E70Q30380038-A2AEDD04-E211-447B-B6A9-4AF93D1D2983Q30839904-9FEF60E4-1B8F-441A-BC47-A48F394C6E78Q33567290-6D258264-36CB-44E3-A88D-EEE4CF15390AQ33714672-2904A320-1F3C-4928-8FEB-6471269F0288Q34081210-2AE901F8-A6F9-431C-8888-120D63762D47Q34260460-7D960089-3E3A-4886-8058-B611A25FFF54Q34775930-802A88D8-C98D-4882-A78B-A83A47AF0997Q35014329-360FFA22-37EE-4625-8C2B-FAEF04DE0EAEQ35027220-7D23B75B-2D0B-486B-B990-EAE03639A8D1Q35092902-70042C3B-D7B1-4F61-AC0A-7D75E716FC17Q35120941-5A758D0B-47CF-422E-9A6E-9FA7B1F76A5CQ35147977-6DAC414E-D404-4BAC-A379-7E4D4BF0C116Q35199447-4A8131F6-5A33-43A9-B24A-F6B56858748FQ35236328-F4AD3C10-13CC-47B1-93E4-275C0A1D2650Q35624667-74495C40-C5C0-42D8-8E9F-0FA55DBC9685Q35671062-2E431656-9BAB-447D-98C7-8A2DCA795433Q35738372-A1D5F8F7-CCCB-4129-BA09-8962B0559152Q35795262-2E830F21-54C6-46F1-95B0-77338A2743C6Q35994360-334E748E-5697-415E-B586-549C48D5B369Q36093194-20CB7FC1-8220-45F4-9572-BF2C6024C3FAQ36403156-588FAAC6-1B1A-4F33-A87F-F147388D2260Q36457876-8C5BD842-41CF-4CA2-9DCE-AB5B28439272Q36489313-1CD37822-D765-48BE-828D-6D7CF5A7E3F0Q36540608-F3E89EF8-7B1F-455B-92F9-325D29B19B33Q36590967-8725D825-AA41-4F4B-BA45-5B8DE92909C6Q37030996-C49514A6-B71B-478D-BD37-D98A412DB5B3Q37123811-089D0E89-F90E-419B-8F28-8A823E04B24DQ37170464-89DC19D6-1F5B-4BF0-BD9C-1273A7E162C3Q37270341-8A248482-0BDA-470C-8E37-8CE4A31D36A5Q37536536-0372F186-381B-4C6A-A5F3-368DC6D42F17
P2860
High-density lipoprotein function, dysfunction, and reverse cholesterol transport.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
High-density lipoprotein function, dysfunction, and reverse cholesterol transport.
@en
type
label
High-density lipoprotein function, dysfunction, and reverse cholesterol transport.
@en
prefLabel
High-density lipoprotein function, dysfunction, and reverse cholesterol transport.
@en
P2093
P2860
P1476
High-density lipoprotein function, dysfunction, and reverse cholesterol transport.
@en
P2093
Bernd Hewing
Jonathan E Feig
Stanley L Hazen
P2860
P304
P356
10.1161/ATVBAHA.112.300133
P407
P577
2012-12-01T00:00:00Z